This compound is a chiral pharmaceutical intermediate featuring a diazabicyclo ring system with carbamoyl and fluoroacetic acid substituents. It is primarily significant as a building block for the synthesis of complex organic molecules.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2209871-79-2
Guaiacol glycidyl ether
pharmaceutical intermediate
4-dimethylamino-3-methyl-2-butanone
pharmaceutical intermediate
3-Azetidinemethanamine dihydrochloride
pharmaceutical intermediate
6-Ethoxy Abacavir
pharmaceutical intermediate
(2R)-2-[[(2S,5R)-2-carbamoyl-4-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl]oxy]-2-fluoroacetic acid
CZCMDCKIUIXEQC-ACZMJKKPSA-N
CC1=C[C@H](N2C[C@@H]1N(C2=O)O[C@@H](C(=O)O)F)C(=O)N
—